Network Health, the insurance arm of Wisconsin-based Froedtert ThedaCare Health, is expanding its partnership with Mark Cuban Cost Plus Drug Co. to include employer-sponsored health plan members. In early 2025, Network Health became one of the first insurers in the…
Pharmacy
The WVU Heart and Vascular Institute and the West Virginia University School of Pharmacy in Morgantown are expanding a program that connects patients with heart failure in rural communities to specialized cardiovascular care through local pharmacies. The program now includes…
AstraZeneca has held talks with Bristol Myers Squibb about a potential merger that would create one of the world’s largest drugmakers with a combined market value of nearly $400 billion, according to an Aug. 2 report from Financial Times. The…
The Michigan Supreme Court ruled July 31 that the state’s attorney general may continue pursuing an investigation into Eli Lilly’s insulin pricing practices under the Michigan Consumer Protection Act, reversing lower court rulings that had blocked the case. In a…
An FDA advisory committee voted 10-3 July 30 that efficacy results from Replimune’s study for RP1 were evaluable and clinically meaningful, advancing the company’s application for the experimental melanoma therapy after the FDA rejected it twice. The Cellular, Tissue, and…
Advertisement
Morgantown, W.Va.-based WVU Medicine has opened the WVUH Community Pharmacy, expanding access to pharmacy services for residents, patients, students and employees. The pharmacy is integrated with the health system’s community pharmacy network, allowing pharmacy staff to work directly with providers…
Active U.S. drug shortages increased to 227 in the second quarter of 2026, marking the third consecutive quarterly increase, according to the American Society of Health-System Pharmacists. Nearly half of all new shortages this year involve medications made by a…
Health system pharmacies face mounting pressure to improve medication safety while managing workforce shortages and growing regulatory requirements. Reducing variation in sterile compounding is a key step towards this end. As the complexity and volume of compounded medications continues to…
Drugmakers have pushed back their resupply estimates for carboplatin, one of four chemotherapy drugs in a monthslong shortage, with some formulations now not expected to return until 2027. Cisplatin, carboplatin, oxaliplatin and ifosfamide, which form the backbone of treatment for…
The Health Resources and Services Administration has revised its 340B Rebate Model Pilot Program, establishing a voluntary pathway for qualifying drug manufacturers to provide 340B ceiling prices through rebates rather than upfront discounts for a limited group of covered outpatient…